COUNCIL FOR AMERICAN MEDICAL INNOVATION (CAMI)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2012

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2012	—	5	2
2011	—	9	2
2010	—	12	2
2009	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
GEPHARDT GROUP GOVERNMENT AFFAIRS	—	15
FAEGRE BAKER DANIELS CONSULTING	—	15

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	16
HOUSE OF REPRESENTATIVES	14
Health & Human Services, Dept of (HHS)	8
Food & Drug Administration (FDA)	6
Natl Economic Council (NEC)	2
White House Office	2
Executive Office of the President (EOP)	1
Natl Institutes of Health (NIH)	1
Office of Management & Budget (OMB)	1
Patent & Trademark Office (PTO)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	24
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	20
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	10
Budget/Appropriations	Budget/Appropriations	4
Economics/Economic Development	Economics/Economic Development	4
Science/Technology	Science/Technology	4
Copyright/Patent/Trademark	Copyright/Patent/Trademark	2
Education	Education	2
Immigration	Immigration	1
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

Cited source text and reported amounts

Cures Acceleration Network; H.R. 3590, Patient Protection and Affordable Care Act

Client expense: — · Firm income: $10,000

Matched citations: H.R. 3590

COUNCIL FOR AMERICAN MEDICAL INNOVATION (CAMI) — Lobbying Disclosure | Poliscope